Austin, Texas, May 11th, 2026, FinanceWireFrontieras is positioned amid increased demand for domesticenergy production.
The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
The US is the world's largest producer of bioethanol as renewable liquid fuel, with more than 200 commercial plants processing over 16 billion gallons per year. Plants typically use dry grind ...
HOUSTON, April 30, 2026 (GLOBE NEWSWIRE) -- via IBN – Frontieras North America (“Frontieras” or the “Company”), an energy and ...
It has been widely reported that around one-third of all the food produced globally is wasted. René Floris, NIZO Food Research Division Manager and member of the FoodNavigator expert advisory panel, ...
Dairy supplier Arla claims ‘revolutionary’ new technology to separate milk into its different protein components opens the door to ‘infinite innovation possibilities’. Milk protein fractionation using ...
Proprietary fractionation method achieves unprecedented yields of purified immune globulin, alpha-1 antitrypsin and albumin with a processing time of 2-3 days CHARLESTON, S.C., October 28, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results